menu
    • menu

    Company profile for Promius Pharma

    DRL-PSE
    News
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology

    03 Apr 2019

    // ECONOMIC TIMES

    Promius promotes digital campaign to empower skin condition patients

    05 Nov 2018

    // Beth Snyder Bulik FIERCE PHARMA

    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco

    23 May 2018

    // PATENT LITIGATION

    DATA COMPILATION
    #PharmaFlow

    Dr Reddy Promius Pharma RM

    Contact Supplier

    Website

    Global ChemShow

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/excipient-market-overview-evonik-launches-high-purity-excipients-india-mandates-disclosures-from-march-2026

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Related CompaniesRelated Companies

    About

    Promius Pharma, LLC, is a branded pharmaceutical company that entered the dermatology market in 2008. Headquartered in Princeton, New Jersey, Promius Pharma is a wholly owned subsidiary of Dr. Reddy's Laboratories, one of India's largest and most respected pharmaceutical companies. Promius Pharma is a new face in the dermatology community and will provide fresh, innovative products and ideas that meet unmet physician and patient needs. We also differentiate our company in our reliance on research and development, in our commitment to using input from physicians to shape our focus and future direction.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Promius PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    107 College Rd E Princeton, NJ 08540
    Telephone
    Telephone
    Client Email
    Email
    API@drreddys.com
    Client Website
    Website
    https://api.drreddys.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology

    03 Apr 2019

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-subsidiary-sells-assigns-us-rights-for-3-brands-to-encore-dermatology/articleshow/68683488.cms

    ECONOMIC TIMES
    03 Apr 2019
    Share Share
    Promius promotes digital campaign to empower skin condition patients
    Promius promotes digital campaign to empower skin condition patients

    05 Nov 2018

    // Beth Snyder Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/skin-you-re-promius-promotes-digital-campaign-to-empower-people-range-skin-conditions

    Beth Snyder Bulik FIERCE PHARMA
    05 Nov 2018
    Share Share
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco

    23 May 2018

    // PATENT LITIGATION

    https://insight.rpxcorp.com/litigation_documents/12926948

    PATENT LITIGATION
    23 May 2018
    Share Share
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Taro Pharmaceuticals
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Taro Pharmaceuticals

    23 May 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/sernivobetamethasone-dipropionate-promius-pharma-v-taro-pharmaceuticals-1527500767.pdf

    PATENT LITIGATION
    23 May 2018
    Share Share
    Dr. Reddy's and its US. subsidiary Promius announce the filing NDA for migraine
    Dr. Reddy's and its US. subsidiary Promius announce the filing NDA for migraine

    02 Apr 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180402005384/en

    BUSINESSWIRE
    02 Apr 2018
    Share Share
    Promius Pharma's Sernivo approved in US as topical steroid
    Promius Pharma's Sernivo approved in US as topical steroid

    05 Feb 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/promius-pharmas-sernivo-approved-in-us-as-topical-steroid-1455104964.pdf

    FDA
    05 Feb 2016
    Share Share

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search